Tech Company Financing Transactions

Shape Therapeutics Funding Round

On 7/19/2021, Shape Therapeutics raised $112 million in investment from Breton Capital Management, Decheng Capital and Mission BioCapital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

219 Terry Ave. N 100
Seattle, WA 98109
USA

Phone

Undisclosed

Website

www.shapetx.com

Email Address

[email protected]

Overview

Shape Therapeutics' next-generation gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Francois Vigneault

        

Chief Financial Officer

John Suliman

        

Chief Operating Officer

Gary Fortin

        

Executive Vice President

Rafael Ponce

        

Vice President

Joseph Biedenkapp

        

Vice President

Ron Hause

        

VP - Bus. Development

Patrick Bigot

        

VP - Finance

William Krause

        

VP - General Counsel

Lisa Ash

        

VP - Operations

Katherine Connor

        

VP - R & D

David Huss

        

Browse more venture capital transactions:

Prev: 7/19/2021: Play2Pay venture capital transaction
Next: 7/19/2021: Captain Fresh venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary